Utilization of a Prenatal Palliative Care Consultation Pathway for Congenital Heart Disease

Insights

Prenatal palliative care improves support for families with congenital heart disease (CHD) infants. Early integration of palliative care enhances provider understanding and utilization for better infant and family well-being.

Area of Science:

  • Pediatric Cardiology
  • Palliative Care
  • Neonatal Health

Background:

  • Survival rates for children with congenital heart disease (CHD) have improved, but complex cases still have significant mortality.
  • Prenatal palliative care offers comprehensive support for infants, parents, and families, involving an interprofessional approach.
  • Limited understanding and utilization of prenatal palliative care exist among pediatric cardiac providers.

Purpose of the Study:

  • To explore pediatric cardiac provider attitudes and knowledge regarding prenatal palliative care for fetuses with complex CHD.
  • To guide increased and appropriate prenatal palliative care consultations.
  • To implement a quality improvement project aimed at enhancing prenatal palliative care access.

Main Methods:

  • Retrospective review of a cardiac database to identify eligible patients for prenatal palliative care.
  • Pre- and post-intervention surveys to assess pediatric cardiac provider attitudes and knowledge.
  • Development and implementation of an educational intervention on prenatal palliative care.

Main Results:

  • 21.5% of maternal patients with fetuses diagnosed with complex CHD met criteria for prenatal palliative care consultation.
  • A referral pathway was developed to increase consultations.
  • Post-intervention surveys showed >93% of providers gained a better understanding of palliative care's appropriate use for support.

Conclusions:

  • Increased provider knowledge of prenatal palliative care leads to greater utilization for comfort and support, not just end-of-life care.
  • Early integration of palliative care at the time of prenatal diagnosis benefits infants and families.
  • Quality improvement initiatives can effectively enhance prenatal palliative care for complex pediatric heart conditions.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
23
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
30
Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.5K
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
109
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
22